Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Koss

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Chemistry & Biology|September 25, 2012
A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survivalNicole A Cohen, Michelle L Stewart, Evripidis Gavathiotis, et al.
Oncotarget|February 11, 2016
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell linesBrian Koss, Jeremy Ryan, Amit Budhraja, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
DNA-PKcs governs LAT-dependent signaling in CD4 <sup>+</sup> and CD8 <sup>+</sup> T cellsRandall R Rainwater, Ana C Azevedo-Pouly, Zachary J Waldrip, et al.
Cell Reports|January 8, 2026
DNA-PKcs controls the cytotoxic T cell response to cancer and transplant allograft through regulating LAT-dependent signalingRandall R Rainwater, Ana C Azevedo-Pouly, Zachary J Waldrip, et al.
Cell Death Discovery|March 4, 2020
Delivery of phosphatidylethanolamine blunts stress in hepatoma cells exposed to elevated palmitate by targeting the endoplasmic reticulumMarcus Trentzsch, Eugene Nyamugenda, Tiffany K Miles, et al.
Immunology and Cell Biology|May 7, 2023
Chemical inhibition of DNA-PKcs impairs the activation and cytotoxicity of CD4<sup>+</sup> helper and CD8<sup>+</sup> effector T cellsAna C Azevedo-Pouly, Lauren E Appell, Lyle Burdine, et al.
Cancer Research|January 25, 2019
Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in MelanomaBradley D Shields, Brian Koss, Erin M Taylor, et al.
Iscience|June 23, 2025
EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanomaJacob L Edmondson, Megan R Reed, Daniel Fil, et al.
Nature Communications|May 31, 2024
Evolved histone tail regulates 53BP1 recruitment at damaged chromatinJessica L Kelliher, Melissa L Folkerts, Kaiyuan V Shen, et al.
Scientific Reports|April 13, 2017
Indicators of responsiveness to immune checkpoint inhibitorsBradley D Shields, Fade Mahmoud, Erin M Taylor, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Chemistry & Biology|September 25, 2012
A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survivalNicole A Cohen, Michelle L Stewart, Evripidis Gavathiotis, et al.
Oncotarget|February 11, 2016
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell linesBrian Koss, Jeremy Ryan, Amit Budhraja, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
DNA-PKcs governs LAT-dependent signaling in CD4 <sup>+</sup> and CD8 <sup>+</sup> T cellsRandall R Rainwater, Ana C Azevedo-Pouly, Zachary J Waldrip, et al.
Cell Reports|January 8, 2026
DNA-PKcs controls the cytotoxic T cell response to cancer and transplant allograft through regulating LAT-dependent signalingRandall R Rainwater, Ana C Azevedo-Pouly, Zachary J Waldrip, et al.
Cell Death Discovery|March 4, 2020
Delivery of phosphatidylethanolamine blunts stress in hepatoma cells exposed to elevated palmitate by targeting the endoplasmic reticulumMarcus Trentzsch, Eugene Nyamugenda, Tiffany K Miles, et al.
Immunology and Cell Biology|May 7, 2023
Chemical inhibition of DNA-PKcs impairs the activation and cytotoxicity of CD4<sup>+</sup> helper and CD8<sup>+</sup> effector T cellsAna C Azevedo-Pouly, Lauren E Appell, Lyle Burdine, et al.
Cancer Research|January 25, 2019
Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in MelanomaBradley D Shields, Brian Koss, Erin M Taylor, et al.
Iscience|June 23, 2025
EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanomaJacob L Edmondson, Megan R Reed, Daniel Fil, et al.
Nature Communications|May 31, 2024
Evolved histone tail regulates 53BP1 recruitment at damaged chromatinJessica L Kelliher, Melissa L Folkerts, Kaiyuan V Shen, et al.
Scientific Reports|April 13, 2017
Indicators of responsiveness to immune checkpoint inhibitorsBradley D Shields, Fade Mahmoud, Erin M Taylor, et al.
Pageof 3